HomeCompareSTRPF vs ABBV

STRPF vs ABBV: Dividend Comparison 2026

STRPF yields 560.22% · ABBV yields 3.06%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 STRPF wins by $149589.37M in total portfolio value
10 years
STRPF
STRPF
● Live price
560.22%
Share price
$0.36
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$149589.47M
Annual income
$110,713,811,877.36
Full STRPF calculator →
ABBV
AbbVie Inc.
● Live price
3.06%
Share price
$217.44
Annual div
$6.65
5Y div CAGR
40.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$102.3K
Annual income
$24,771.77
Full ABBV calculator →

Portfolio growth — STRPF vs ABBV

📍 STRPF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSTRPFABBV
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, STRPF + ABBV cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
STRPF pays
ABBV pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

STRPF
Annual income on $10K today (after 15% tax)
$47,619.05/yr
After 10yr DRIP, annual income (after tax)
$94,106,740,095.76/yr
ABBV
Annual income on $10K today (after 15% tax)
$259.96/yr
After 10yr DRIP, annual income (after tax)
$21,056.00/yr
At 15% tax rate, STRPF beats the other by $94,106,719,039.75/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of STRPF + ABBV for your $10,000?

STRPF: 50%ABBV: 50%
100% ABBV50/50100% STRPF
Portfolio after 10yr
$74794.79M
Annual income
$55,356,918,324.56/yr
Blended yield
74.01%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ABBV right now

STRPF
No analyst data
Altman Z
1.9
Piotroski
2/9
ABBV
Analyst Ratings
27
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$256.15
+17.8% upside vs current
Range: $223.00 — $299.00
Altman Z
2.0
Piotroski
8/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

STRPF buys
0
ABBV buys
0
No recent congressional trades found for STRPF or ABBV in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSTRPFABBV
Forward yield560.22%3.06%
Annual dividend / share$2.00$6.65
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.6%
Portfolio after 10y$149589.47M$102.3K
Annual income after 10y$110,713,811,877.36$24,771.77
Total dividends collected$146296.77M$61.0K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: STRPF vs ABBV ($10,000, DRIP)

YearSTRPF PortfolioSTRPF Income/yrABBV PortfolioABBV Income/yrGap
1← crossover$66,722$56,022.41$11,550$430.00+$55.2KSTRPF
2$420,734$349,341.13$13,472$627.96+$407.3KSTRPF
3$2,508,928$2,058,742.09$15,906$926.08+$2.49MSTRPF
4$14,158,123$11,473,570.09$19,071$1,382.55+$14.14MSTRPF
5$75,659,914$60,510,722.38$23,302$2,095.81+$75.64MSTRPF
6$383,166,039$302,209,931.18$29,150$3,237.93+$383.14MSTRPF
7$1,840,350,184$1,430,362,522.78$37,536$5,121.41+$1840.31MSTRPF
8$8,389,777,510$6,420,602,813.34$50,079$8,338.38+$8389.73MSTRPF
9$36,332,394,689$27,355,332,752.62$69,753$14,065.80+$36332.32MSTRPF
10$149,589,474,194$110,713,811,877.36$102,337$24,771.77+$149589.37MSTRPF

STRPF vs ABBV: Complete Analysis 2026

STRPFStock

Starr Peak Mining Ltd., an exploration stage junior mining company, engages in the identification, acquisition, and exploration of mineral properties in Canada. The company explores for gold. It holds a 100% interest in NewMetal Property comprising 53 mineral claims covering an area of 1,420 hectares located in the northwestern Quebec. The company was formerly known as Starr Peak Exploration Ltd. and changed its name to Starr Peak Mining Ltd. in March 2021. Starr Peak Mining Ltd. was incorporated in 1981 and is headquartered in Vancouver, Canada.

Full STRPF Calculator →

ABBVHealthcare

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Full ABBV Calculator →
📬

Get this STRPF vs ABBV comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

STRPF vs SCHDSTRPF vs JEPISTRPF vs OSTRPF vs KOSTRPF vs MAINSTRPF vs JNJSTRPF vs MRKSTRPF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.